SHINYA YOKOYAMA
Papers
1
Total Citations
3
H-Index
1
About
Shinya Yokoyama is a leading interventional radiologist whose research focuses on advancing transarterial chemoembolization (TACE) techniques for hepatocellular carcinoma (HCC). His major contribution lies in optimizing drug delivery systems, particularly through the development and clinical evaluation of a porous glass membrane-pumping emulsification device (GMD). This innovative technology creates high-percentage water-in-oil emulsions with homogeneous, stable droplets, significantly improving the locoregional therapeutic effects of TACE. In his landmark 2022 study on solitary HCC, Yokoyama demonstrated that GMD-assisted TACE enhances treatment precision and efficacy, a finding that has garnered early attention in the field. While his most-cited paper currently holds 3 citations, its impact is growing as interventional oncology increasingly prioritizes standardized, reproducible embolic agents. Yokoyama’s work bridges engineering and clinical practice, offering a scalable solution to a persistent challenge in liver cancer therapy. His contributions are particularly notable for their potential to reduce tumor recurrence and improve patient outcomes, positioning him as a rising authority in image-guided cancer interventions.
Research Focus
Key Achievements
Top Papers
- 1